O'Leary A - Search Results

1

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future.

de Bruijn W, Ibáñez C, Frisk P, Bak Pedersen H, Alkan A, Vella Bonanno P, Brkičić LS, Bucsics A, Dedet G, Eriksen J, Fadare JO, Fürst J, Gallego G, Godói IP, Guerra Júnior AA, Gürsöz H, Jan S, Jones J, Joppi R, Kerman S, Laius O, Madzikwa N, Magnússon E, Maticic M, Markovic-Pekovic V, Massele A, Ogunleye O, O'Leary A, Piessnegger J, Sermet C, Simoens S, Tiroyakgosi C, Truter I, Thyberg M, Tomekova K, Wladysiuk M, Vandoros S, Vural EH, Zara C, Godman B. de Bruijn W, et al. Front Pharmacol. 2016 Jul 22;7:197. doi: 10.3389/fphar.2016.00197. eCollection 2016. Front Pharmacol. 2016. PMID: 27516740 Free PMC article.

2

Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infection.

Gray E, O'Leary A, Kieran JA, Fogarty E, Dowling T, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN). Gray E, et al. J Viral Hepat. 2016 Sep;23(9):677-86. doi: 10.1111/jvh.12532. Epub 2016 Mar 21. J Viral Hepat. 2016. PMID: 26996144

3

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.

Gray E, Pasta DJ, Norris S, O'Leary A; Irish Hepatitis C Outcomes and Research Network (ICORN). Gray E, et al. BMC Health Serv Res. 2017 Apr 19;17(1):288. doi: 10.1186/s12913-017-2188-1. BMC Health Serv Res. 2017. PMID: 28424064 Free PMC article.

4

The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.

Nguyen LT, Gray E, O'Leary A, Carr M, De Gascun CF; Irish Hepatitis C Outcomes Research Network. Nguyen LT, et al. PLoS One. 2016 Oct 6;11(10):e0163900. doi: 10.1371/journal.pone.0163900. eCollection 2016. PLoS One. 2016. PMID: 27711230 Free PMC article.

5

Pharmacoeconomic evaluation in Ireland: a review of the process.

Tilson L, O'Leary A, Usher C, Barry M. Tilson L, et al. Pharmacoeconomics. 2010;28(4):307-22. doi: 10.2165/11318790-000000000-00000. Pharmacoeconomics. 2010. PMID: 20222754

6

The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.

Kieran J, Schmitz S, O'Leary A, Walsh C, Bergin C, Norris S, Barry M. Kieran J, et al. Clin Infect Dis. 2013 Jan;56(2):228-35. doi: 10.1093/cid/cis880. Epub 2012 Oct 16. Clin Infect Dis. 2013. PMID: 23074309 Review.

7

Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals.

Nguyen LT, Gray E, Dean J, Carr M, Connell J, De Gascun C, Nguyen LA, O'Leary A, Bergin C, Hall W, Norris S. Nguyen LT, et al. Antivir Ther. 2015;20(8):865-9. doi: 10.3851/IMP2964. Epub 2015 Apr 29. Antivir Ther. 2015. PMID: 25920764

8

Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients.

Gimeno-Ballester V, Mar J, O'Leary A, Adams R, San Miguel R. Gimeno-Ballester V, et al. Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):85-93. doi: 10.1080/17474124.2016.1222271. Epub 2016 Aug 25. Expert Rev Gastroenterol Hepatol. 2017. PMID: 27500437

9

Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.

Gray E, O'Leary A, Bergin C, Cannon M, Courtney G, Crosbie O, De Gascun CF, Fanning LJ, Feeney E, Houlihan DD, Kelleher B, Lambert JS, Lee J, Mallon P, McConkey S, McCormick A, McKiernan S, McNally C, Murray F, Sheehan G, Stewart S, Walsh C, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN). Gray E, et al. Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):593-601. doi: 10.1080/17474124.2017.1292850. Epub 2017 Feb 22. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28276815

10

Generic substitution of antiretrovirals: patients' and health care providers' opinions.

Kieran JA, O'Reilly E, O'Dea S, Bergin C, O'Leary A. Kieran JA, et al. Int J STD AIDS. 2017 Oct;28(12):1239-1246. doi: 10.1177/0956462417696215. Epub 2017 Mar 2. Int J STD AIDS. 2017. PMID: 28632475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters